24.45000 EUR
0.25
1.03%
Last update Dec 16, 7:31 PM CET
Main market
Day range
24.010000
24.46000
Previous close
24.20000
Open
24.010000
Access this stock data via API
Subscribe
Takeda Pharmaceutical Company Limited
24.45
0.25
1.03%

Financials

Income statement

Fundamentals currency is JPY
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 6.1B 6.1B 5.8B 6.3B
Cost of revenue 2.1B 2.1B 2.1B 2.3B
Gross profit 4.0B 4.0B 3.7B 4.0B
Operating expense
Research & development 886.5M 789.9M 1.2B 934.3M
Selling general and admin 1.4B 1.4B 1.6B 1.5B
Other operating expenses 239.1M 33.1M -615.8M 802.8M
Operating income 378.8M 1.0B 376.3M -123.2M
Non operating interest income
Income 243.7M 404.9M -44.8M -38.4M
Expense 456.4M 588.3M -123.1M 173.5M
Other income expense -11.4M -2.9M -911.9M 480.0M
Pretax income 154.7M 826.9M -589.0M 145.0M
Tax provision 219.1M 144.7M -23.1M 14.1M
Net income -64.4M 682.3M -566.0M 130.8M
Basic EPS 79.4
Diluted EPS 78.2
Basic average shares 8.6M
Diluted average shares 8.7M
EBITDA 1.7B 2.4B 402.6M 1.3B
Net income from continuing op. -64.4M 682.3M -566.0M 130.8M
Minority interests -395.3K -197.6K -312.9K -252.5K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 36 minutes

14:23
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).